Innate and adaptive immunity to Candida albicans: A new view of an old paradigm

Revista Iberoamericana de Micologia

Volumn 16, Issue 1, 1999, Pages 4-7

  Mencacci, Antonella ^a   Cenci, Elio ^a   Del Sero, Giuseppe ^a   D'Ostiani, Cristiana Fè ^a   Montagnoli, Claudia ^a   Bacci, Angela ^a   Bistoni, Francesco ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANDIDA ALBICANS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; REVIEW; RISK FACTOR;

EID: 0032896418     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Fidel Jr PL, Sobel JD. The role of cell-mediated immunity in candidiasis. Trends Microbiol 1994; 6: 202-206.
2. Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis new perspectives for therapy. Trends Microbiol 1995;3:237-240.
3. Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38: 1020-1028
4. Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Strain-dependent differences in susceptibility of mice to experimental candidosis. J Infect Dis 1986; 154: 906-908.
5. Romani L, Mencacci A, Cenci E. et al. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 1993; 150 925-929.
6. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development J Infect Dis 1995; 171:1279-1288
7. Romani L, Mencacci A, Cenci E, et al Naturall killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect Immun 1993; 61: 3769-3774
8. Mencacci A, Cenci E, Del Sero G, et al. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-a double-deficient mice infected with Candida albicans. Int Immunol 1998; 10: 37-48
9. Cenci E, Mencacci A, Del Sera G, et al. IFN-γ is required for IL-12 responsiveness in mice with Candida albicans infection J Immunol 1998, 161: 3543-3550.
10. Mencacci A, Cenci E, Bistoni F, et al Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. Res Immunol 1998; 149: 352-361.
11. Djeu JY. Cytokines and antifungal immunity Adv Exp Med Biol 1992, 319 217-223.
12. Cutler JE. The Candida albicans phosphomannan complex in Candida-host interactions Res Immunol 1998; 149: 299-308.
13. Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J immunol 1993; 23: 1034-1038
14. Romani L, Puccetti P, Mencacci A, et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152: 3514-3521.
15. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis. I Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-γ) production. Clin Exp Immunol 1996; 105: 205-212.
16. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP. Chronic mucocutaneous candidiasis II. Class and subclass of antibodies responses in vivo and in vitro. Clin Exp Immunol 1996; 105: 213-219.
17. Roilides E, Sein T, Schaufele R, Chanock SJ, Walsh TJ. Increased serum concentration of interleukin-10 in patients with hepatosplenic candidiasis. J Infect Dis 1998; 178 589-599.
18. Morelli R, Rosenberg LT. Role of complement during experimental Candida infection in mice Infect Immun 1971; 3: 521-523.
19. Ashman RB. Candida albicans: pathogenesis, immunity and host defence. Res Immunol 1998; 149: 281-288.
20. Romani L, Puccetti P, Bistoni F. Biological role of helper T-cell subsets in candidiasis. Chem Immunol 1996; 63: 113-137.
21. Fidel PL Jr, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis Clin Micobiol Rev 1996; 9: 335-348
22. Romani L. Animal models for candidiasis. Curr Prot Immunol, in press
23. Odds FC. Candida and candidosis London, Baillière-Tindall, 1988, 104-110.
24. Romani L, Cenci E, Mencacci A, et al. Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun 1992; 60 4950-4952.
25. Spaccapelo R, Romani L, Tonnetti L, et al. TGF-β is important in determining the in vivo susceptibility or resistance in mice infected with Candida albicans. J Immunol 1995; 155: 1349-1360.
26. Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1-11.
27. Romani L, Bistoni F, Mencacci A, Cenci E, Spaccapelo R, Puccetti P. IL 12 in Candida albicans infections Res Immunol 1996; 146 532-538.
28. Tonnetti L, Spaccapelo R, Cenci E, et al Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25: 1559-1565.
29. Romani L. The T cell response to fungi. Curr Opin Immunol 1997; 9: 484-490.
30. Mencacci A, Spaccapelo R, Del Sero G, et al CD4+ T-helper-cell responses in mice with low-level Candida albicans infection. Infect Immun 1996; 64: 4907-4914.
31. Mencacci A, Del Sero G, Cenci E, et al. IL-4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 1998; 187: 307-317.
32. Mencacci A, Cenci E, Del Sero G, et al. IL-10 is required for development of protective CD4+ T helper type 1 cell responses in IL-12-deficient mice upon Candida albicans infection. J Immunol 1998, 161: 6228-6237.
33. Fearon JD, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996, 272: 50-54.
34. Romani L, Bistoni F, Puccetti P. Initiation of T helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem Immunol 1997; 68: 110-135.
35. Bendelac A, Fearon DT. Innate pathways that control acquired immunity. Curr Opin Immunol 1997; 9: 1-3.
36. Fè d'Ostiani C, Mencacci A, Cenci E, et al Antifungal and immunomodulatory activities of murine dendritic cells. 10th International Congress of Immunology, New Delhi, 1998:103.
37. Romani L, Mencacci A, Cenci E, Del Sero G, Bistoni F, Puccetti P An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J Imrnunol 1997, 158: 2356-2362.
38. Romani L, Mencacci A, Cenci E, et al. Neutrophils production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol 1997; 158-5349-5356.
39. Cassone A, Chiani P, Quinti I, Torosantucci A. Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients. J Leukoc Biol 1997; 62: 60-66
40. Walsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections: All neutropenic patients are not the same. Clin Infect Dis 1994; 18: 793-798.
41. Bodey GP, Anaissie EJ Chronic systemic candidiasis. Eur J Clin Microbiol Infect Dis 1989; 8: 855-857.
42. Bow EJ, Loewen R, Cheang MS, Schacter B Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995; 21: 361-369.
43. La Rocco M, Burgert SJ. Fungal infections in the transplant recipient and laboratory methods for diagnosis. Rev Iberoam Micol 1997, 14: 143-146.
44. Rodriguez-Adrian LJ, Grazziutti ML, Rex HJ, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: Is recovery from neutropenia all that is needed? Clin Infect Dis 1998; 26: 1270-1278.
45. Kullberg BJ, Anaissie EJ. Cytokines as therapy for opportunistic fungal infections. Res Immunol 1998; 149: 478-488.
46. Stevens DA. Combination immunotherapy and antifungal chemotherapy. Clin Infect Dis 1998, 26 1266-1269.
47. Poynton HC. Immune modulation by cytokines in the treatment of opportunistic infections. Curr Opin Infect Dis 1997; 10: 275-280.